Estimation of glucose utilization in a type 2 diabetes mellitus patient on insulin analogs with tumor hypoglycemia induced by IGF-II

Cryer, 2011, Glucose homeostasis and hypoglycemia, 1552 Heald, 2006, Most commercial insulin assays fail to detect recombinant insulin analogues, Ann. Clin. Biochem., 43, 306, 10.1258/000456306777695690 Merrigan, 2012, Cross-reactivity of modern insulin analogs insulin detemir and insulin glulisine with six automated insulin immunoassays Bodnar, 2014, Management of non-islet-cell tumor hypoglycemia: a clinical review, J. Clin. Endocrinol. Metab., 99, 713, 10.1210/jc.2013-3382 Deurenberg, 1991, Body mass index as a measure of body fatness: age- and sex specific prediction formulas, Br. J. Nutr., 65, 105, 10.1079/BJN19910073 Eastman, 1992, Glucose utilization in a patient with hepatoma and hypoglycemia: assessment by a positron emission tomography, J. Clin. Invest., 89, 1958, 10.1172/JCI115803 Shoemaker, 2010, One-step metabolomics: carbohydrates, organic and amino acids quantified in a single procedure, J. Vis. Exp., 40, e2014 Koppenol, 2011, Otto Warburg's contributions to current concepts of cancer metabolism, Nat. Rev. Cancer, 11, 325, 10.1038/nrc3038 Dynkevich, 2013, Tumors, IGF-II and hypoglycemia: insights from the clinic, the laboratory and the historical archive, Endocr. Rev., 34, 798, 10.1210/er.2012-1033 Moller, 1991, Basal and insulin stimulated substrate metabolism in tumour induced hypoglycaemia: evidence for increased muscle glucose uptake, Diabetologia, 34, 17, 10.1007/BF00404019 Chung, 1996, Mechanisms of tumor-induced hypoglycemia with intraabdominal hemangiopericytoma, J. Clin. Endocrinol. Metab., 81, 919